Patient Leaflet Updated 29-May-2024 | Dr. Reddy's Laboratories (UK) Ltd
Fulvestrant Dr. Reddy's 250 mg Solution For Injection in Pre-Filled Syringe
Fulvestrant 250 mg Solution For Injection in Pre-Filled Syringe
Fulvestrant
1. What Fulvestrant is and what it is used for
2. What you need to know before you use Fulvestrant
3. How to use Fulvestrant
4. Possible side effects
5. How to store Fulvestrant
6. Contents of the pack and other information
Fulvestrant contains the active substance fulvestrant, which belongs to the group of estrogen blockers. Estrogens, a type of female sex hormones, can in some cases be involved in the growth of breast cancer.
Fulvestrant is used either:
When Fulvestrant is given in combination with palbociclib, it is important that you also read the package leaflet for palbociclib. If you have any questions about palbociclib, please ask your doctor.
Talk to your doctor or pharmacist or nurse before using Fulvestrant if any of these apply to you:
Fulvestrant is not indicated in children and adolescents under 18 years.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
In particular, you should tell your doctor if you are using anticoagulants (medicines to prevent blood clots).
You must not use fulvestrant if you are pregnant. If you can become pregnant, you should use effective contraception while you are being treated with fulvestrant and for 2 years after your last dose.
You must not breast-feed while on treatment with fulvestrant.
Fulvestrant is not expected to affect your ability to drive or use machines. However, if you feel tired after treatment do not drive or use machines.
Ethanol
This medicine contains 500 mg alcohol (ethanol) in 5 ml solution. The amount in one dose (two 5 ml syringe) of this medicine is equivalent to less than 25 ml beer or 10 ml wine. The amount of alcohol in this medicine is not likely to have an effect in adults and adolescents. The alcohol in this medicine may alter the effects of other medicines. Talk to your doctor or pharmacist if you are taking other medicines. If you are addicted to alcohol, talk to your doctor or pharmacist before taking this medicine.
Benzyl alcohol
This medicine contains 500 mg benzyl alcohol in each5 ml vial. Benzyl alcohol may cause allergic reactions.
Ask your doctor or pharmacist for advice if you have a liver or kidney disease. This is because large amounts of benzyl alcohol can build-up in your body and may cause side effects (called “metabolic acidosis”).
Benzyl benzoate
This medicine contains 750 mg benzyl benzoate in each 5 ml vial.
Castor oil
May cause severe allergic reactions.
Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
The recommended dose is 500 mg fulvestrant (two 250 mg/5 ml injections) given once a month, with an additional 500 mg dose given 2 weeks after the initial dose.
Your doctor or nurse will give you fulvestrant as a slow intramuscular injection, one into each of your buttocks.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Very common side effects (may affect more than 1 in 10 people)
Common side effects (may affect up to 1 in 10 people)
Uncommon side effects (may affect up to 1 in 100 people)
* Includes side effects for which the exact role of fulvestrant cannot be assessed due to the underlying disease.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme, website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton or syringe labels after EXP. The expiry date refers to the last day of that month.
This medicine does not require any special temperature storage conditions.
Keep the pre-filled syringe in the original package, in order to protect from light.
Your healthcare professional will be responsible for the correct storage, use and disposal of fulvestrant.
This medicine may pose a risk to the aquatic environment. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Fulvestrant is a clear, colourless to yellow, viscous solution free from visible particles in a pre-filled syringe fitted with a tamper-evident closure, containing 5 ml solution for injection. Two syringes must be administered to receive the 500 mg recommended monthly dose.
Fulvestrant has 4 pack presentations: a pack containing 1 glass pre-filled syringe, a pack containing 2 glass pre-filled syringes, a pack containing 4 glass pre-filled syringes, and a pack containing 6 prefilled syringes. Safety needles for connection to each barrel and a finger grip on each pre-filled syringe are also provided.
Not all pack sizes may be marketed.
This leaflet was last revised in 08/2023
Dr. Reddy's Laboratories (UK) Limited, 410 Cambridge Science Park, Milton Road, Cambridge, CB4 0PE, UK
+44 (0)1748 828 873
+44 (0)1223 651 475
+44 (0)1223 728 010
http://www.drreddys.com/united-kingdom